These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 37113000)
1. Current Clinical Landscape and Global Potential of Bacteriophage Therapy. Hitchcock NM; Devequi Gomes Nunes D; Shiach J; Valeria Saraiva Hodel K; Dantas Viana Barbosa J; Alencar Pereira Rodrigues L; Coler BS; Botelho Pereira Soares M; Badaró R Viruses; 2023 Apr; 15(4):. PubMed ID: 37113000 [TBL] [Abstract][Full Text] [Related]
2. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts. Royer S; Morais AP; da Fonseca Batistão DW Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609 [TBL] [Abstract][Full Text] [Related]
4. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going? Luong T; Salabarria AC; Roach DR Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528 [TBL] [Abstract][Full Text] [Related]
9. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779 [TBL] [Abstract][Full Text] [Related]
10. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics. Usman SS; Uba AI; Christina E Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288 [TBL] [Abstract][Full Text] [Related]
11. Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy. Yeh TK; Jean SS; Lee YL; Lu MC; Ko WC; Lin HJ; Liu PY; Hsueh PR Int J Antimicrob Agents; 2022 Jan; 59(1):106475. PubMed ID: 34767917 [TBL] [Abstract][Full Text] [Related]
12. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again. Squires RA N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297 [TBL] [Abstract][Full Text] [Related]
13. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope. Kulshrestha M; Tiwari M; Tiwari V Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110 [TBL] [Abstract][Full Text] [Related]
14. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy. Segall AM; Roach DR; Strathdee SA Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502 [TBL] [Abstract][Full Text] [Related]
15. Ameliorating the antimicrobial resistance crisis: phage therapy. Saha D; Mukherjee R IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079 [TBL] [Abstract][Full Text] [Related]
16. Current challenges and future opportunities of phage therapy. Pires DP; Costa AR; Pinto G; Meneses L; Azeredo J FEMS Microbiol Rev; 2020 Nov; 44(6):684-700. PubMed ID: 32472938 [TBL] [Abstract][Full Text] [Related]
18. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences. Chanishvili N Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515 [TBL] [Abstract][Full Text] [Related]
19. The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects. Anyaegbunam NJ; Anekpo CC; Anyaegbunam ZKG; Doowuese Y; Chinaka CB; Odo OJ; Sharndama HC; Okeke OP; Mba IE Microbiol Res; 2022 Nov; 264():127155. PubMed ID: 35969943 [TBL] [Abstract][Full Text] [Related]
20. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens. Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]